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OBJECTIVEdObservational studies show breaking up prolonged sitting has beneficial asso-
ciations with cardiometabolic risk markers, but intervention studies are required to investigate
causality. We examined the acute effects on postprandial glucose and insulin levels of uninter-
rupted sitting compared with sitting interrupted by brief bouts of light- or moderate-intensity
walking.
RESEARCHDESIGNANDMETHODSdOverweight/obese adults (n = 19), aged 45–65
years, were recruited for a randomized three-period, three-treatment acute crossover trial: 1)
uninterrupted sitting; 2) seated with 2-min bouts of light-intensity walking every 20 min; and 3)
seated with 2-min bouts of moderate-intensity walking every 20 min. A standardized test drink
was provided after an initial 2-h period of uninterrupted sitting. The positive incremental area
under curves (iAUC) for glucose and insulin (mean [95%CI]) for the 5 h after the test drink (75 g
glucose, 50 g fat) were calculated for the respective treatments.
RESULTSdThe glucose iAUC (mmol/L) z h after both activity-break conditions was reduced
(light: 5.2 [4.1–6.6]; moderate: 4.9 [3.8–6.1]; both P , 0.01) compared with uninterrupted
sitting (6.9 [5.5–8.7]). Insulin iAUC (pmol/L) z h was also reduced with both activity-break
conditions (light: 633.6 [552.4–727.1]; moderate: 637.6 [555.5–731.9], P, 0.0001) compared
with uninterrupted sitting (828.6 [722.0–950.9]).
CONCLUSIONSdInterrupting sitting time with short bouts of light- or moderate-intensity
walking lowers postprandial glucose and insulin levels in overweight/obese adults. This may
improve glucose metabolism and potentially be an important public health and clinical inter-
vention strategy for reducing cardiovascular risk.
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P rolonged sitting time is associatedwith premature cardiovascular andall-cause mortality, independent of
leisure-time physical activity and adiposity
(1,2). Findings from the 2003–2004 and
2005–2006 U.S. National Health and Nu-
trition Examination Survey (NHANES)
and the 2004–2005 Australian Diabetes,
Obesity and Lifestyle (AusDiab) study
showed that objectively measured total
sedentary time was detrimentally associ-
ated with cardiometabolic risk markers
(3,4). In contrast, frequent interruptions
(breaks) to sedentary time (defined as the
transition from sedentary to an active
state for $1 min) were beneficially asso-
ciated. In both populations, the mean
break duration was approximately 4 min
and was characterized by light-intensity
activity (approximately 500 accelerometer
counts/min). Furthermore, these rela-
tionships persisted after accounting for
moderate-to-vigorous activity, suggest-
ing that frequent short breaks in seden-
tary time may impart unique benefit. A
next step for the science of sedentary be-
havior is to identify the metabolic under-
pinnings of these deleterious and
beneficial relationships.
Regular ingestion of high-calorie meals
rich in processed carbohydrates and satu-
rated fat can lead to transient exaggerated
postprandial spikes in glucose and lipids,
which promote oxidative stress that
triggers a biochemical inflammatory cas-
cade, endothelial dysfunction, and sym-
pathetic hyperactivity (5–9). These
postprandial excursions, when repeated
multiple times each day, can create a mi-
lieu conducive for the development of
atherosclerosis and cardiovascular dis-
ease (9,10). Postprandial hyperglycemia
or glucose variability has been associated
with indices of atherosclerotic progres-
sion, including carotid intima-media
thickening (11,12) and coronary artery
calcium (13) as well as development or
progression of retinopathy (14,15), car-
diovascular events (16), and death (17) in
patients with type 2 diabetes. Guidelines
for cardiovascular health include mini-
mizing the magnitude of postprandial
hyperglycemia (18).
Postprandial glucose levels and in-
sulin sensitivity are beneficially influ-
enced by regular moderate-intensity
exercise training (19–21). Recent epide-
miologic findings have also shown 2-h
plasma glucose to be beneficially associated
with objectively measured light-intensity
activity (22). Light-intensity activity may
be effective for reducing postprandial
glucose, and corroborative experimental
evidence exists. In middle-aged women,
15- and 40-min bouts of light-intensity ac-
tivity both led to a reduction in the acute
blood glucose response to a carbohydrate-
rich meal relative to 2-h seated rest (23).
Compared with sitting, light nonexercise
activities of intensities between 1.1 and
2.7 metabolic equivalents can improve
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insulin action in young men and women
(24). In addition, 20 min of light exercise
(40% of maximal power output) per-
formed 45min after the ingestion of a stan-
dardized pre-exercise carbohydrate load in
young men resulted in similar glucose and
insulin responses to that of moderate and
vigorous exercise (65 and 80%) (25). This
evidence, together with observational
study findings on breaking up sedentary
time (22), points to the need for further
experimental studies. Specifically, there is
the need to examine the effects of frequent
brief interruptions to prolonged sitting in-
volving light-intensity ormoderate-intensity
activity (as distinct from continuous ambu-
latory activity) on postprandial glucose and
insulin. This may have important implica-
tions for settings where continuous ambu-
latory activity may not be feasible or
practical, such as workplaces.
We examined the acute effects of un-
interrupted sitting on postprandial plasma
glucose and serum insulin, compared with
sitting interrupted by short 2-min bouts
of light- or moderate-intensity walking
in overweight middle-aged adults. We hy-
pothesized that postprandial blood glucose
control during sitting would be improved
by brief intermittent bouts of activity, ir-





This randomized, three-period, three-
treatment crossover trial was approved
by the AlfredHospital Human Ethics Com-
mittee and was in accordance with the
Declaration of Helsinki. Participants pro-
vided signed, written informed consent.
The study is registered as a clinical trial with
the Australian New Zealand Clinical Trials
Registry (ACTRN12609000656235).
Participants attended three separate
visits to the laboratory to complete each
of the trial conditions in a randomized
order: 1) uninterrupted sitting; 2) sitting
interruptedby light-intensity activity breaks;
and 3) sitting interrupted by moderate-
intensity activity breaks. Because an acute
bout of physical activity may enhance in-
sulin sensitivity for up to 72h (26), we used
a minimum wash-out of 6 days between
each condition to eliminate potential car-
ryover effects of the activity conditions.
Participants and enrollment process
Participants were recruited between April
2009 and August 2010 from the general
community (Fig. 1). Eligibility criteria in-
cluded age between 45 and 65 years and
BMI .25 kg/m2 (overweight or obese),
representing a population with a height-
ened diabetes risk (27). Exclusion criteria
were pregnancy, clinically diagnosed
diabetes, BMI .45 kg/m2, non-English
speaking, taking glucose-lowering and/or
lipid-lowering medication, employment
in a nonsedentary occupation, currently
watching,2 h of television per day, reg-
ularly engaged in moderate-intensity
exercise 150min/week for at least 3months,
and known physical activity contraindi-
cations, major illness/injury (acute or
chronic), or other health issues that may
have limited the ability to perform the nec-
essary activity bouts.
Participants were invited to an orien-
tation and were provided with a detailed
study overview, gave consent, and were
screened for additional exclusion criteria.
This included a medical examination
performed by a physician (D.A.B.) that
involved a medical history, physical
examination, resting blood pressure, and a
resting 12-lead electrocardiogram. Eligi-
ble participants received a brief famili-
arization and were given the opportunity
to become accustomed to the light- and
moderate-intensity walking speeds and
were also familiarized with use of the
Borg Rate of Perceived Exertion (RPE)
scale (28). During the moderate-intensity
walking familiarization, the treadmill speed
that yielded an RPE rating between 12 and
14 for each participant was recorded and
used during that experimental condition
Study protocol
Figure 2 shows the study protocol. Partic-
ipants were provided with verbal and
written instructions to refrain from any
exercise, alcohol, and caffeine in the 48
h before each of the three trial conditions.
During this time, physical activity was ob-
jectively measured with an Actigraph
GT1M accelerometer (Actigraph, Pensa-
cola, FL) worn around the hip during
waking hours. Data were recorded in
Figure 1dTrial CONSORT diagram.
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1-min epochs, with accelerometer counts
$100/min classified as active time. This
was further differentiated as moderate-to-
vigorous intensity activity ($1,952
counts/min) and light-intensity activity
(100–1,951 counts/min) (29). Wear time
andactivityduration, type, and intensityun-
dertaken during any nonwear periods were
recorded in activity diaries. This informa-
tion, in conjunction with an automated ac-
celerometerwear-time estimation, was used
to derive daily wear time.
Participants reported to the labora-
tory between 0700 and 0800 h, having
fasted overnight. A catheter was inserted
into an antecubital vein for hourly blood
sampling. After the initial blood collec-
tion (time point: 22 h), participants re-
mained seated for 2 h to achieve a steady
state before the consumption of a stan-
dardized test drink (time point: 0 h).
The 200-mL test drink consisted of 75 g
carbohydrate (100% corn maltodextrin
powder; Natural Health, Australia) and
50 g fat (Calogen; Nutricia, Australia).
The specific nutritional components were
energy, 3,195 kJ; fat, 50.0 g; saturated fat,
5 g; monounsaturated fat, 30.4 g; polyun-
saturated fat, 14.3 g; carbohydrate, 75 g;
total sugars, 12.8 g; protein, nil;fiber,,1 g;
sodium, 46.9 mg; and water, 90 g. The
grounds for inclusion of the fat content
were based on 1) better simulation of a
mixed meal and 2) its influence of slowing
the ingested glucose production (gastroin-
testinal emptying) to spread the plasma
glucose and insulin responses over more
of the selected 5-h treatment period. Partic-
ipants were then guided through the
respective trial condition protocols for the
remaining 5 h. The hourly blood collection
was undertaken before activity bouts dur-
ing the activity days (trial conditions 2 and
3 outlined below). The research staff di-
rectly supervised participants throughout
each trial to ensure that full compliance
with the trial protocols was achieved.
The trial conditions are listed as
follows:
1. Uninterrupted sitting: Participants re-
mained seated throughout the exper-
imental period and were instructed to
minimize excessive movement, only
rising from the chair to void.
2. Sitting + light-intensity activity breaks:
Participants rose from the seated po-
sition every 20 min throughout the
experimental period (to achieve three
breaks per hour), and completed a
2-min bout of light-intensity walking
on a motorized treadmill with a level
surface at 3.2 km/h. They then returned
to the seated position. This procedure
was undertaken on 14 occasions,
providing a total of 28 min of light-
intensity activity.
3. Sitting +moderate-intensity activity breaks:
Identical procedure to the sitting + light-
intensity activity breaks condition, but
participants completed 2-min bouts
of moderate-intensity walking on the
treadmill at between 5.8 and 6.4 km/h
every 20min, providing a total of 28min
of moderate-intensity activity.
Participantswatched television orDVDs;
read books, magazines, or newspapers;
performed light paperwork; or worked
on a laptop computer throughout the
three conditions. As expected, during the
5-h postprandial period in the moder-
ate-intensity activity breaks condition,
the mean 6 SE accelerometer-measured
time spent in moderate-intensity activity
was 24.0 6 1.8 min compared with
0.66 0.4 min in the light-intensity condi-
tion. Activity levels were further monitored
at the completion of each activity bout us-
ing the Borg RPE scale. The mean 6 SE
(range: min–max) RPEs during the light-
intensity and moderate-intensity activity
break conditions were 8 6 0.4 (6–11)
and 12 6 0.4 (8–14), respectively.
Randomization and masking
Participants were randomized to one of
six possible trial-condition orders using
balanced blocks prepared for male and
female participants. An independent re-
search institution prepared the computer-
generated randomization lists and sealed
envelopes for randomization (BSR for
Windows, Johns Hopkins Oncology Cen-
ter, Baltimore, MD). Once informed con-
sent was obtained, a third party opened
the sealed randomization envelope re-
vealing the trial-condition order. The
pathology technicians and team statisti-
cian were also blinded to trial condition.
Plasma preparation and analytic
methods
Code-labeled samples were sent to an
independent laboratory for the determina-
tion of glucose and insulin levels. Glucose
was measured in plasma (fluoride/oxalate)
Figure 2dStudy protocol. Std, standard.
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on the day of testing using a hexokinase
method on an Architect ci16200 ana-
lyzer (Abbott Diagnostics, North Ryde,
NSW, Australia). Serum, collected hourly,
was stored at 2808C for insulin analysis
after the study. Serum insulin was mea-
sured by chemiluminescent microparti-
cle immunoassay (Architect ci16200
analyzer, Abbott Diagnostics). Samples
collected for each participant during the
respective trial conditions were in-
cluded in the same insulin assay to avoid
interassay variability. The intra-assay
coefficient of variation for insulin was
between 2 and 4%.
Statistical analysis
Sample size calculations were based on
pilot data of mean changes in the incre-
mental area under the curve (iAUC) for
glucose and insulin (10% for glucose,
60% for insulin), estimates of population
variability (SD 1% for glucose, 30% for
insulin), and assuming a correlation co-
efficient of 0.5 between repeated mea-
sures of the outcomes. We estimated that
19 paired observations were needed to
achieve a power of 0.90 to detect the
smallest expected effect size in the pri-
mary outcome variables between the
three interventions, while adopting a
two-tailed testing and a 0.05 probability
level.
Generalized estimating equations
with exchangeable working correlation
to account for dependency in the data
(repeated measures) were used to evaluate
the differential effects of the trial condi-
tions on the outcomes (30,31). All models
were adjusted for potentially important
covariates explaining residual outcome
variance (age, sex, and weight), baseline
predrink outcome values, and period ef-
fects. Carryover effects were not formally
tested, given the.6-day washout between
trials and that there were no differences
in baseline biochemical, anthropometric,
dietary, or physical activity measures be-
fore each intervention (Table 1) (26,31).
Postestimation contrasts were used to ex-
amine the differential effects of pairs of con-
ditions. Generalized estimating equation
models were used to examine between-
trial condition differences in pretrial waist
circumference, weight, plasma glucose,
serum insulin, physical activity, and dietary
measures. Level of P , 0.05 was consid-
ered significant. All statistical analyses
were performed using Stata 10.1 software
(StataCorp LP). Data are reported as
mean 6 SD and mean (95% CI) in the
text and tables unless otherwise indicated,
and in Fig. 3 marginal means 6 SE are
presented.
RESULTSdThe trial Consolidated
Standards of Reporting Trials (CONSORT)
diagram is shown in Fig. 1. Of the 22 par-
ticipants who commenced the study, 19
(11 men, 8 women; mean age, 53.86 4.9
years; mean BMI, 31.26 4.1 kg/m2) com-
pleted all three trials and were included in
the analyses. A completed case analysis
(rather than intention-to-treat) was under-
taken because the reasons for withdrawal
(difficulties with intravenous cannulation
for two participants, a syncopal episode
for the other) were unrelated to initial
values or their response during the first
condition.
The biochemical, anthropometric, di-
etary, and accelerometer-derived physical
activity data before each of the respective
trials are reported in Table 1. There were
no significant differences between trials
for any of these measures.
After adjustment for age, sex, weight,
period effects, and predrink levels, the
mean net glucose response to the test
drink (5-h positive iAUC) was 24.1%
lower after sitting with light-intensity
activity (5.2 mmol/L z h [4.1–6.6], P ,
0.01) and 29.6% lower after sitting with
moderate-intensity activity (4.9 mmol/L z h
[3.8–6.1]; P, 0.0001) compared with un-
interrupted sitting (6.9 mmol/L z h [5.5–
8.7]) (Fig. 3A and B). The mean plasma
glucose concentrations at 2-h postdrink
were 8.0 mmol/L (7.2–8.8) for uninter-
rupted sitting, 7.5 mmol/L (6.8–8.3) for
sitting with light-intensity physical activ-
ity, and 7.2 mmol/L (6.5–8.0) for sitting
with moderate-intensity physical activity
(P. 0.05 for light- andmoderate-intensity
conditions relative to uninterrupted
sitting).
After adjustment for age, sex, weight,
period effects, and predrink levels, the
mean insulin-positive iAUC was reduced
by 23% after the sitting with light-
intensity (633.6 pmol/L z h [552.4–727.1],
P , 0.0001) and moderate-intensity con-
ditions (637.6 pmol/L z h [555.5–731.9],
P , 0.0001) relative to the uninterrupted
(828.6 pmol/L z h [722.0–950.9]) sitting
(Fig. 3C and D). The mean serum insulin
concentration at 2-h postdrink was signifi-
cantly lower for sitting with moderate-
intensity physical activity (412.9 pmol/L
[340.4–500.7], P, 0.05), but not for sit-
ting with light-intensity physical activity
(324.3 pmol/L [267.4–393.3], P = 0.4),
relative to uninterrupted sitting (375.7
pmol/L [308.2–458.0]).
No significantdifferenceswereobserved
in the positive iAUC observed between the
two activity conditions, nor any age or sex
interactions for any of the outcomes.
CONCLUSIONSdThese findings pro-
vide initial experimental confirmation of
hypotheses generated by epidemiologic
observational studies on the deleterious
health consequences of prolonged sedentary
Table 1dBiochemical, anthropometric, physical activity, and dietary values before
each trial
Uninterrupted Sitting + activity breaks
sitting Light-intensity Moderate-intensity
Weight (kg) 90.7 6 18.5 90.5 6 18.1 90.4 6 18.2
Plasma glucose (mmol/L)* 5.1 6 0.5 5.0 6 0.5 5.0 6 0.5
Serum insulin (pmol/L)* 49.0 6 25.4 53.9 6 30.1 48.2 6 25.3
Physical activity
Time accelerometer worn (min) 833 6 113 881 6 103 870 6 105
Sedentary time (min) 544 6 120 582 6 123 579 6 112
Activity time (min)
Light-intensity 263 6 91 274 6 77 267 6 69
Moderate-vigorous 26.1 6 26.6 24.6 6 23.5 24.4 6 29.5
Diet†
Total energy intake (kJ/day) 8,393 6 2,733 8,569 6 1,994 7,792 6 2,511
Total fat (energy %) 30.5 6 6.8 31.3 6 5.2 30.9 6 7.5
Total carbohydrate (energy %) 51.6 6 7.3 48.5 6 8.5 50.8 6 8.1
Total protein (energy %) 18.0 6 3.5 19.5 6 4.3 18.3 6 4.9
Data are presented as mean6 SD. No significant between-trial condition differences were observed in pretrial
measures (all P. 0.15). *Measurement immediately before the drink (time 0). †During the 48 h before the
trial, dietary intakes were assessed from weighed/measured food records using dietary analysis software
(Foodworks, Xyris software, Highgate Hill, Queensland, Australia).
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time (too much sitting as distinct from too
little exercise). Of particular importance is
the potential for reducing cardiovascular
disease risk by briefly breaking up pro-
longed periods of sitting with activity of at
least light intensity. Brief interruptions to
sitting led to significant reductions in post-
prandial glucose and insulin, irrespective
of the activity intensity. The 24–30%
lowering in the plasma glucose iAUC and
the 23% lowering in the insulin iAUC seen
after the activity break conditions, at the
very least, is comparable in magnitude to
an acute bout ofmoderate-intensity aerobic
or resistance exercise in overweight/obese
individuals (32).
Our findings are the first to docu-
ment, among overweight/obese adults, an
elevated postprandial glucose and insulin
response during an acute bout of pro-
longed sitting, relative to sitting with brief
activity interruptions. Among young non-
obese adults, significant reductions in
whole-body insulin sensitivity have been
observed after 1 day of prolonged sitting
(24). The magnitudes of changes ob-
served in postprandial glucose and insulin
during the uninterrupted sitting condition
in our study are consistent (;23–30%)
with the changes in metabolic outcomes re-
ported after 1 day of prolonged sitting (24).
The lowering of postprandial glucose and
insulin suggests both increased insulin sen-
sitivity and reduced insulin secretion, the
latter effect consistent with preservation of
pancreatic b-cell function. Intervention
study findings demonstrating that blunting
of postprandial spikes in glucose improves
inflammation and endothelial function (33)
and reduces carotid intima-media thickness
(11,33) suggest that the blunted glucose re-
sponse seen in our study through the inclu-
sion of three brief (2-min) activity breaks
per hour during prolonged sitting may
ameliorate such consequences of postpran-
dial hyperglycemia (9,18).
Although larger reductions in post-
prandial glycemia have yielded clinical ben-
efits to surrogate cardiovascular end points,
including carotid intima-media thickness
(8), smaller differentials in the postprandial
glucose seen in response to pharmaceutical
agents, generally comparable in magnitude
to those seen in the activity break condi-
tions, have been linked to reductions in
oxidative stress, circulating adhesion
molecules, and endothelial function in
patients with and without type 2 diabetes
(6,8,33). Additional research using mea-
sures of inflammation and endothelial
function will be necessary to further elu-
cidate the influence of frequent breaks
from sitting and whether the exaggerated
postprandial glucose response observed
after 5 h of uninterrupted sitting is more
pronounced when imposed over multiple
days. Potential long-term consequences,
both beneficial and deleterious, of differ-
ent sitting-time patterns are needed to
strengthen the case for relevant public
health and clinical initiatives.
These findings support the hypothesis
that brief interruptions to sedentary time
with a minimum of light-intensity physical
activity can attenuate acute postprandial
plasma glucose and serum insulin response
during prolonged sitting. Importantly, the
brevity of the interruptions to sitting (2min)
indicates that such breaks would not count
toward the minimum amount of aerobic
Figure 3dThe effect of the three trial conditions on postprandial plasma glucose levels (A);
positive (5-h postprandial) glucose iAUC (B); postprandial serum insulin levels (C); and positive
(5-h postprandial) iAUC (D). Data for postprandial plasma glucose and serum insulin levels
represent mean6 SE. Data for glucose and insulin positive iAUC represent marginal means6 SE
(adjusted for age, sex, body weight, period effects, and predrink levels). *Significantly different
from uninterrupted sitting condition, P , 0.001. †Significantly different from uninterrupted
sitting condition, P , 0.01.
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activity necessary for substantial health ben-
efits within current physical activity guide-
lines because at least 10-min episodes of
activity are stipulated (34). However, con-
sistent with studies of the effects of contin-
uous exercise on glucose metabolism (35),
the sum of total activity time over a 5-h
periodwas 28min.A logical next stepwould
be to build on these findings to design a
study that would provide a head-to-head
comparison of a single continuous exercise
bout to the breaking up of prolonged sit-
ting protocol used in this study.
The moderate-intensity activity break
condition was relatively strenuous for some
of our study participants. Our original pro-
tocol called for a consistent 6.4 km/h for all
participants, but we found it necessary to
slightly reduce the speed for some so that
they could complete the prescribed 2-min
moderate-intensity bouts without discom-
fort. Thus, the higher-intensity breaks con-
dition was close to the practical maximal
feasible intensity for these overweight/obese
individuals and likely close to the tolerable
upper limit of activity for expected physio-
logic benefit.
Our trial does have some potential
limitations. First, it examined acute ef-
fects of a 1-day exposure to prolonged
uninterrupted versus interrupted sitting;
thus, implications cannot be extrapolated to
long-term exposures. Second, it examined
activity bouts offixed frequency and length.
Systematic variations in length and fre-
quency of activity bouts and possible mod-
erating effects of factors such as sex and
adiposity status should be examined.
Our experimental protocol involved
brief and regular interruptions (2 min of
activity for every 20 min sitting) to pro-
longed sitting time. Interrupting seden-
tary time in this way could be feasible in
domestic and workplace settings where
adults sit for prolonged periods (36).
However, further experimental evidence
that can define dose-response relation-
ships is required. For example, evidence
from animal studies (37) suggests that it
may be important primarily to interrupt
the contractile inactivity in postural mus-
cles that takes place during prolonged
sitting. From body weight–dependent
equations (38), it is estimated that treadmill
walking at 3.2 km/h in people weighing
90.5 kg demands an energy expenditure
of only 18.8 kJ/min, yet most forms of
nonexercise activity that naturally inter-
rupt sitting would be expected to yield
even less energy expenditure. Although
the body weight–dependent equations
do not cover the 5.6–6.4 km/h walking
speed used in this trial, it would be real-
istic to expect that the energy expendi-
ture for the moderate walking bouts
would be expected to exceed the 25.6 kJ/
min estimated for walking at 4.8 km/h.
Simply regularly standing up for a short
period may have beneficial metabolic ef-
fects. Estimating the caloric expenditure
of such changes would be informative;
the increased substrate utilization that is re-
quired to meet differences in energy de-
mands when transitioning from sitting to
standing may be an important mechanism
(37,38). However, whether simple brief
standing, as opposed to longer activity
bouts, will be protective for metabolic
health, remains to be determined.
Given the high prevalence of over-
weight and obesity among those of low so-
cioeconomic status living in affluent
populations (39) and the average “greying”
of demographic profiles, our study partic-
ipants are representative of large numbers
at risk for developing type 2 diabetes and
subsequent cardiovascular complications.
Pragmatic trials with large numbers of par-
ticipants would be highly informative (40),
such as demonstrating metabolic health ef-
fects of reducing and breaking up sitting
time in the workplace over sustained
Figure 3dContinued.
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periods of time (i.e., months or years)
among representative groups of working
adults.
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